These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21327129)

  • 21. Plasmid Replicons for the Production of Pharmaceutical-Grade pDNA, Proteins and Antigens by
    Duarte SOD; Monteiro GA
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral administration of Lactococcus lactis expressing Helicobacter pylori Cag7-ct383 protein induces systemic anti-Cag7 immune response in mice.
    Kim SJ; Lee JY; Jun DY; Song JY; Lee WK; Cho MJ; Kim YH
    FEMS Immunol Med Microbiol; 2009 Dec; 57(3):257-68. PubMed ID: 19807786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A study on anti-caries activity of genetic recombinant vaccine of Streptococcus lactis. II. Immunization in vein with recombinant S. lactis in pregnant rabbits].
    Liu J; Fan M; Bian Z; Ling J
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1998 May; 16(2):108-10, 140. PubMed ID: 12214406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity of oral vaccination with Lactococcus lactis derived vaccine candidate antigen (UreB) of Helicobacter pylori fused with the human interleukin 2 as adjuvant.
    Zhang HX; Qiu YY; Zhao YH; Liu XT; Liu M; Yu AL
    Mol Cell Probes; 2014 Feb; 28(1):25-30. PubMed ID: 24036137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lactococcus lactis-based vaccines from laboratory bench to human use: an overview.
    Bahey-El-Din M
    Vaccine; 2012 Jan; 30(4):685-90. PubMed ID: 22154771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal immunisation with recombinant Lactococcus lactis displaying either anchored or secreted forms of Proteus mirabilis MrpA fimbrial protein confers specific immune response and induces a significant reduction of kidney bacterial colonisation in mice.
    Scavone P; Miyoshi A; Rial A; Chabalgoity A; Langella P; Azevedo V; Zunino P
    Microbes Infect; 2007 Jun; 9(7):821-8. PubMed ID: 17540603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-dependent systemic antibody responses and immunisation-associated changes in mice orally and nasally immunised with Lactococcus lactis expressing a malaria parasite protein.
    Moorthy SA; Yasawardena SG; Ramasamy R
    Vaccine; 2009 Aug; 27(36):4947-52. PubMed ID: 19545652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterologous protein production and delivery systems for Lactococcus lactis.
    Nouaille S; Ribeiro LA; Miyoshi A; Pontes D; Le Loir Y; Oliveira SC; Langella P; Azevedo V
    Genet Mol Res; 2003 Mar; 2(1):102-11. PubMed ID: 12917806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell surface display system for Lactococcus lactis: a novel development for oral vaccine.
    Raha AR; Varma NR; Yusoff K; Ross E; Foo HL
    Appl Microbiol Biotechnol; 2005 Jul; 68(1):75-81. PubMed ID: 15635459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production and targeting of the Brucella abortus antigen L7/L12 in Lactococcus lactis: a first step towards food-grade live vaccines against brucellosis.
    Ribeiro LA; Azevedo V; Le Loir Y; Oliveira SC; Dieye Y; Piard JC; Gruss A; Langella P
    Appl Environ Microbiol; 2002 Feb; 68(2):910-6. PubMed ID: 11823235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production, secretion and purification of a correctly folded staphylococcal antigen in Lactococcus lactis.
    Samazan F; Rokbi B; Seguin D; Telles F; Gautier V; Richarme G; Chevret D; Varela PF; Velours C; Poquet I
    Microb Cell Fact; 2015 Jul; 14():104. PubMed ID: 26178240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and microbiological response of mice to intranasal inoculation with Lactococcus lactis expressing Group A Streptococcus antigens, to be used as an anti-streptococcal vaccine.
    García PC; Paillavil BA; Scioscia N; Dale JB; Legarraga P; Salazar-Echegarai FJ; Bueno SM; Kalergis AM; Wozniak A
    Microbiol Immunol; 2018 Nov; 62(11):711-719. PubMed ID: 30357922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biosafety evaluation of recombinant live oral bacterial vaccines in the context of European regulation.
    Favre D; Viret JF
    Vaccine; 2006 May; 24(18):3856-64. PubMed ID: 16115705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biocontainment of genetically modified organisms by synthetic protein design.
    Mandell DJ; Lajoie MJ; Mee MT; Takeuchi R; Kuznetsov G; Norville JE; Gregg CJ; Stoddard BL; Church GM
    Nature; 2015 Feb; 518(7537):55-60. PubMed ID: 25607366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Lactococcus lactis-vectored oral vaccine induces protective immunity of mice against enterotoxigenic Escherichia coli lethal challenge.
    Song J; Zhao L; Song M
    Immunol Lett; 2020 Sep; 225():57-63. PubMed ID: 32569608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a new DNA vaccine based on mycobacterial ESAT-6 antigen delivered by recombinant invasive Lactococcus lactis FnBPA+.
    Pereira VB; Saraiva TD; Souza BM; Zurita-Turk M; Azevedo MS; De Castro CP; Mancha-Agresti P; Dos Santos JS; Santos AC; Faria AM; Leclercq S; Azevedo V; Miyoshi A
    Appl Microbiol Biotechnol; 2015 Feb; 99(4):1817-26. PubMed ID: 25503506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lactic acid bacteria--20 years exploring their potential as live vectors for mucosal vaccination.
    Wyszyńska A; Kobierecka P; Bardowski J; Jagusztyn-Krynicka EK
    Appl Microbiol Biotechnol; 2015 Apr; 99(7):2967-77. PubMed ID: 25750046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting diseases with genetically engineered Lactococcus lactis and its course towards medical translation.
    Villatoro-Hernandez J; Montes-de-Oca-Luna R; Kuipers OP
    Expert Opin Biol Ther; 2011 Mar; 11(3):261-7. PubMed ID: 21204744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suicide microbes on the loose.
    Ramos JL; Andersson P; Jensen LB; Ramos C; Ronchel MC; Díaz E; Timmis KN; Molin S
    Biotechnology (N Y); 1995 Jan; 13(1):35-7. PubMed ID: 9634748
    [No Abstract]   [Full Text] [Related]  

  • 40. Heterologous expression of an immunogenic pneumococcal type 3 capsular polysaccharide in Lactococcus lactis.
    Gilbert C; Robinson K; Le Page RW; Wells JM
    Infect Immun; 2000 Jun; 68(6):3251-60. PubMed ID: 10816470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.